Company / Current Liabilities
PUMA BIOTECHNOLOGY, INC. Current Liabilities History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$81.3M
FY2025
5-year range
$77.5M / $109.6M
FY2021-FY2025
Trend
-15.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has fluctuated over the past 9 years, ranging from $58M in FY2017 to $114M in FY2020.
Based on SEC 10-K filings.
$81M in FY2025 with a 5-year CAGR of -6.6%.
Improved from $99M to $81M over the past 2 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +1.6%
- 5-Year CAGR
- -6.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -6.6%, indicating a declining trend.
- In FY2025, current liabilities decreased 15.5% year-over-year.
- Peak current liabilities was recorded in FY2020.
- Lowest current liabilities in the period was in FY2017.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $81.3M | -15.5% |
| FY2024 | $96.1M | -3.3% |
| FY2023 | $99.4M | +28.3% |
| FY2022 | $77.5M | -29.3% |
| FY2021 | $109.6M | -4.1% |
| FY2020 | $114.3M | +25.8% |
| FY2019 | $90.8M | +35.3% |
| FY2018 | $67.1M | +15.0% |
| FY2017 | $58.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026